Contact the Editorial Desk

Editorial correspondence

Peptide Emporium welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about BPC-157, TB-500, GHK-Cu, KPV, or either blend that should be on the references page. Corrections that improve accuracy are the most useful messages we receive.

The most useful notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source.

Editorial mailbox: editors@peptideemporium.com

What this desk cannot do

A few things fall clearly outside what this site can address. Peptide Emporium is a literature digest — not a clinic and not a vendor — so we cannot:

• Advise on, recommend, or comment on human use of any compound discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a research finding applies to a specific person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Respond to questions from athletes subject to anti-doping testing about using any of these compounds, given that several are WADA-prohibited.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Editorial correspondence may be delayed; the mailbox is monitored intermittently.